By Drew Armstrong, Bloomberg |
November 1, 2012
Pfizer Inc., the world’s biggest drugmaker, narrowed its 2012 forecast after reporting third- quarter earnings that met analyst estimates and sales that fell short of expectations.
Look ahead: Economic calendar
Chinese demand low supply boost crude
S&P 500 could be losing upside momentum
Natural gas at an inflection point?
Binary fair value
How low can corn go?